In addition, lnc-DILC modulates the crosstalk between TNF-α/ NF-κB signalling and IL-6/STAT3, resulting in a decreased hepatic inflammation and liver cancer stem cell proliferation [50]. This evidence concerns the gene STAT3 and liver cancer.